Therefore, understanding the precise factors contributing to TDP-43 aggregation—such as the potential convergence of NEK1 and cyclin F signaling—could provide valuable insights into ALS pathogenesis and novel therapeutic targets. The gene discussed is CCNF; the disease is amyotrophic lateral sclerosis.